Biocon ọgwụ maka COVID 19 ALZUMAb® (Itolizumab)

Covid 19th

Ọgwụ Biocon maka COVID-19: ALZUMAb® (Itolizumab)

Ọrịa COVID-19 enweela mmetụta dị ukwuu n'ụwa, na-ebute nnukwu ọnwụ nke ndụ yana ndakpọ akụ na ụba zuru ebe niile. Mkpa ọgwụgwọ na ọgwụ mgbochi dị irè iji luso nje a ọgụ dị oke mkpa. Biocon, onye isi ụlọ ọrụ biopharmaceutical, ewepụtala ọgwụ akpọrọ ALZUMAb® (Itolizumab) iji gwọọ COVID-19.

Kedu ihe bụ ALZUMAb® (Itolizumab)?

ALZUMAb® (Itolizumab) bụ ọgwụ mgbochi mmadụ nke ejirila na India ruo ọtụtụ afọ iji gwọọ psoriasis, ọrịa anụ ahụ na-adịghị ala ala. Na June 2020, onye na-ahụ maka ọgwụ na India (DCGI) kwadoro iji ALZUMAb® (Itolizumab) maka ojiji ihe mberede na ndị ọrịa COVID-19 nwere nnukwu nsogbu iku ume iku ume (ARDS).

Kedu ka ALZUMAb® (Itolizumab) si arụ ọrụ?

ALZUMAb® (Itolizumab) na-arụ ọrụ site na ijikọ na protein a kapịrị ọnụ akpọrọ CD6 nke egosipụtara n'elu sel T, ụdị sel mgbochi. Site na ijikọ na CD6, ALZUMAb® (Itolizumab) na-egbochi ịgbalite na mmụba nke mkpụrụ ndụ T, nke nwere ike ibute nzaghachi mgbochi oke ma ọ bụ oke mmiri ozuzo cytokine na ndị ọrịa COVID-19. Oke mmiri ozuzo cytokine nwere ike ibute oke nku ume yana ọdịda iku ume, na-eduga ọnụ ọgụgụ ọnwụ dị elu na ndị ọrịa COVID-19.

Nnwale ụlọ ọgwụ nke ALZUMAb® (Itolizumab)

Biocon mere nnwale ụlọ ọgwụ nke Abụọ nke ALZUMAb® (Itolizumab) n'ime ndị ọrịa COVID-19 nwere ARDS dị oke ma ọ bụ nke siri ike. Ọnwụnwa ahụ debanyere ndị ọrịa 30, nke 20 natara ALZUMAb® (Itolizumab) na 10 natara ọkọlọtọ nlekọta. Nsonaazụ nke nnwale ahụ gosiri na ALZUMAb® (Itolizumab) belatara nke ukwuu ọnụọgụ ọnwụ na ndị ọrịa COVID-19 nwere ARDS dị oke ma ọ bụ nke siri ike. Ọnụọgụ ọnwụ na otu ALZUMAb® (Itolizumab) bụ 15%, ma e jiri ya tụnyere 40% n'ụdị nlekọta.

Na mgbakwunye, ALZUMAb® (Itolizumab) kwalitere ikuku oxygen ma belata mbufụt na ndị ọrịa COVID-19. A kwadoro ọgwụ ahụ nke ọma n'enweghị ihe ọ bụla dị njọ na-egosi.

Ọnwụnwa ụlọ ọgwụ nke Abụọ nke ALZUMAb® (Itolizumab) sochiri nnwale ụlọ ọgwụ nke Phase III, nke debanyere ndị ọrịa 30 nwere COVID-19 na-agafeghị oke ma dị njọ. Nsonaazụ nke ikpe nke Atọ na-echere.

mmechi

ALZUMAb® (Itolizumab) egosila nsonaazụ na-ekwe nkwa na nnwale ụlọ ọgwụ maka ịgwọ ndị ọrịa COVID-19 nwere ARDS dị oke ma ọ bụ nke siri ike. Ọgwụ a na-arụ ọrụ site na ijikọ na CD6 yana igbochi ịgbalite na mmụba nke mkpụrụ ndụ T, nke nwere ike ibute oke mmiri ozuzo cytokine na ndị ọrịa COVID-19. A kwadoro ALZUMAb® (Itolizumab) maka iji ihe mberede mee ihe na India, a na-amụkwa nchekwa ya na arụmọrụ ya na ule ụlọ ọgwụ na-aga n'ihu. Ọ bụrụ na nsonaazụ nnwale nke Oge III dị mma, ALZUMAb® (Itolizumab) nwere ike ịbụ nhọrọ ọgwụgwọ bara uru maka ndị ọrịa COVID-19.